Diabetes and heart Disease Medications will be affordable

Diabetes and heart
Disease Medications
35 per cent will be affordable.
In the next few weeks, the price of these drugs
NPPA decided
               The National Pharmaceutical Pricing
Authority said.
Price of certain molecules by NPPA
Control is included. The prices of several key molecules
NPPA will be in control.
By NPPA 50 anti -
Diabetic, Heart
The disease drug
The prices are fixed.
652 already in the list of essential medicines
             There are drugs last year
These drugs by the NP PA
Prices are fixed. Heart
57 of disease.
Per cent of drugs are under price control
While diabetes drugs 21
Market value per cent is under control. Estimation
That being imposed Glaiclajaid, Glimapirid,
Sitagliptin, Veglibos, Mlodipin, telmisartan, Rosuwastatin,
Ramipril drugs such as heparin and
The prices will be cheaper.
              Companies will damage
In this regard, it says Viseshsjञon
Drug companies can cause considerable damage.
NPPA's decision to kill
Sanofi India, Abbott,
Ranbaxy Laboratories, Sun Pharma,
Cadila Healthcare, Dr Reddy's, Cipla, Glenmark
Pharma and Lupin will be on. The price of drugs
Serious differences, their impact on prices. First
Market prices are determined according to the price of drugs
But now the prices have been fixed.             Although domestic
Companies influence the decision
But it will not
Sanofi, including multinational
The company will have an impact on the domestic Indian
More trades in the market. Herewith
Prices of many pharmaceutical companies already
Are much higher and the decision
Greater effect on those coming
Is unlikely. Corporate profits
But they will not have much impact, but at this point
Can not be ruled out that the
For those battling illness, a
Great relief.